GSK PLC CEDEAR EACH REPR 1/4 ADR (USD)GSK PLC CEDEAR EACH REPR 1/4 ADR (USD)GSK PLC CEDEAR EACH REPR 1/4 ADR (USD)

GSK PLC CEDEAR EACH REPR 1/4 ADR (USD)

No trades
See on Supercharts

GSKD fundamentals

An in-depth look to GSK PLC CEDEAR EACH REPR 1/4 ADR (USD) operating, investing, and financing activities

GSKD free cash flow for Q1 25 is 1.14 B USD. For 2024, GSKD free cash flow was 5.33 B USD and operating cash flow was 6.91 B USD.

Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM
Free cash flowYoY growth